NCT07320807 Effects of Extracorporeal Shock Wave Therapy After Flexor Tendon Injury
| NCT ID | NCT07320807 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kirsehir Ahi Evran Universitesi |
| Condition | Tendon Injury - Hand |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-01-15 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study aims to investigate the effects of extracorporeal shock wave therapy, applied to the intervention group in addition to the rehabilitation program applied to the control and intervention groups, on range of motion, pain, grip strength, and dexterity after hand flexor tendon injury.
Eligibility Criteria
Inclusion Criteria: * • . Volunteering * . Being 8-12 weeks post-operatively after flexor tendon repair * . Having undergone flexor tendon zone II-IV surgical repair Exclusion Criteria: * . Infection * • . Open wound * . Pregnancy * . History of finger or wrist fracture * . Inflammatory rheumatic disease * . Malignant tumor mass
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07320807 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Tendon Injury - Hand. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07320807 currently recruiting?
Yes, NCT07320807 is actively recruiting participants. Contact the research team at fzt.kapan@gmail.com for enrollment information.
Where is the NCT07320807 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07320807 clinical trial?
NCT07320807 is sponsored by Kirsehir Ahi Evran Universitesi. The trial plans to enroll 56 participants.